ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000258553.1	ABT-263 (navitoclax)	Lung squamous cell carcinoma	0.005444011	Resistant
ENSG00000258553.1	ABT-263 (navitoclax)	Skin cutaneous melanoma	0.039720616	Resistant